- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-FUL.2: 6 residues within 4Å:- Chain A: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain F- Hydrogen bonds: A:N.188, A:S.191, A:R.219, A:N.188, A:K.190
- Water bridges: A:T.108, A:R.219, F:Q.311, A:N.106
- Hydrophobic interactions: A:N.106
NAG-FUL.15: 6 residues within 4Å:- Chain B: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain G- Hydrogen bonds: B:N.188, B:S.191, B:R.219, B:N.188, B:K.190
- Water bridges: B:R.219, G:Q.311, B:N.106
- Hydrophobic interactions: B:N.106
NAG-FUL.28: 6 residues within 4Å:- Chain C: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain E- Hydrogen bonds: C:N.188, C:S.191, C:R.219, C:N.188, C:K.190
- Water bridges: C:T.108, C:R.219, E:Q.311, C:N.106
- Hydrophobic interactions: C:N.106
NAG-FUL.41: 6 residues within 4Å:- Chain D: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:1 interactions with chain H, 4 interactions with chain D- Water bridges: H:Q.311, D:R.219, D:N.106
- Hydrogen bonds: D:N.188, D:S.191, D:R.219, D:N.188, D:K.190
- Hydrophobic interactions: D:N.106
NAG-FUL.54: 6 residues within 4Å:- Chain E: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:4 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:N.188, E:S.191, E:R.219, E:N.188, E:K.190
- Water bridges: E:T.108, E:R.219, A:Q.311, E:N.106
- Hydrophobic interactions: E:N.106
NAG-FUL.67: 6 residues within 4Å:- Chain F: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:1 interactions with chain C, 4 interactions with chain F- Water bridges: C:Q.311, F:T.108, F:R.219, F:N.106
- Hydrogen bonds: F:N.188, F:S.191, F:R.219, F:N.188, F:K.190
- Hydrophobic interactions: F:N.106
NAG-FUL.80: 6 residues within 4Å:- Chain G: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:4 interactions with chain G, 1 interactions with chain D- Hydrogen bonds: G:N.188, G:S.191, G:R.219, G:N.188, G:K.190
- Water bridges: G:R.219, D:Q.311, G:N.106
- Hydrophobic interactions: G:N.106
NAG-FUL.93: 6 residues within 4Å:- Chain H: N.106, N.188, K.190, S.191, R.219, K.476
5 PLIP interactions:1 interactions with chain B, 4 interactions with chain H- Water bridges: B:Q.311, H:R.219, H:N.106
- Hydrogen bonds: H:N.188, H:S.191, H:R.219, H:N.188, H:K.190
- Hydrophobic interactions: H:N.106
- 8 x NA: SODIUM ION(Non-functional Binders)
NA.4: 3 residues within 4Å:- Chain A: F.525
- Chain D: F.525
- Ligands: NA.43
No protein-ligand interaction detected (PLIP)NA.17: 3 residues within 4Å:- Chain B: F.525
- Chain C: F.525
- Ligands: NA.30
No protein-ligand interaction detected (PLIP)NA.30: 3 residues within 4Å:- Chain B: F.525
- Chain C: F.525
- Ligands: NA.17
No protein-ligand interaction detected (PLIP)NA.43: 3 residues within 4Å:- Chain A: F.525
- Chain D: F.525
- Ligands: NA.4
No protein-ligand interaction detected (PLIP)NA.56: 3 residues within 4Å:- Chain E: F.525
- Chain H: F.525
- Ligands: NA.95
No protein-ligand interaction detected (PLIP)NA.69: 3 residues within 4Å:- Chain F: F.525
- Chain G: F.525
- Ligands: NA.82
No protein-ligand interaction detected (PLIP)NA.82: 3 residues within 4Å:- Chain F: F.525
- Chain G: F.525
- Ligands: NA.69
No protein-ligand interaction detected (PLIP)NA.95: 3 residues within 4Å:- Chain E: F.525
- Chain H: F.525
- Ligands: NA.56
No protein-ligand interaction detected (PLIP)- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 3 residues within 4Å:- Chain A: S.487, T.488, T.508
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain A: D.378, Q.380, R.381
Ligand excluded by PLIPCL.9: 3 residues within 4Å:- Chain A: R.515
- Chain G: R.509
- Ligands: SO4.8
Ligand excluded by PLIPCL.18: 3 residues within 4Å:- Chain B: S.487, T.488, T.508
Ligand excluded by PLIPCL.20: 3 residues within 4Å:- Chain B: D.378, Q.380, R.381
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain B: R.515
- Chain F: R.509
- Ligands: SO4.21
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain C: S.487, T.488, T.508
Ligand excluded by PLIPCL.33: 3 residues within 4Å:- Chain C: D.378, Q.380, R.381
Ligand excluded by PLIPCL.35: 3 residues within 4Å:- Chain C: R.515
- Chain H: R.509
- Ligands: SO4.34
Ligand excluded by PLIPCL.44: 3 residues within 4Å:- Chain D: S.487, T.488, T.508
Ligand excluded by PLIPCL.46: 3 residues within 4Å:- Chain D: D.378, Q.380, R.381
Ligand excluded by PLIPCL.48: 3 residues within 4Å:- Chain D: R.515
- Chain E: R.509
- Ligands: SO4.47
Ligand excluded by PLIPCL.57: 3 residues within 4Å:- Chain E: S.487, T.488, T.508
Ligand excluded by PLIPCL.59: 3 residues within 4Å:- Chain E: D.378, Q.380, R.381
Ligand excluded by PLIPCL.61: 3 residues within 4Å:- Chain D: R.509
- Chain E: R.515
- Ligands: SO4.60
Ligand excluded by PLIPCL.70: 3 residues within 4Å:- Chain F: S.487, T.488, T.508
Ligand excluded by PLIPCL.72: 3 residues within 4Å:- Chain F: D.378, Q.380, R.381
Ligand excluded by PLIPCL.74: 3 residues within 4Å:- Chain B: R.509
- Chain F: R.515
- Ligands: SO4.73
Ligand excluded by PLIPCL.83: 3 residues within 4Å:- Chain G: S.487, T.488, T.508
Ligand excluded by PLIPCL.85: 3 residues within 4Å:- Chain G: D.378, Q.380, R.381
Ligand excluded by PLIPCL.87: 3 residues within 4Å:- Chain A: R.509
- Chain G: R.515
- Ligands: SO4.86
Ligand excluded by PLIPCL.96: 3 residues within 4Å:- Chain H: S.487, T.488, T.508
Ligand excluded by PLIPCL.98: 3 residues within 4Å:- Chain H: D.378, Q.380, R.381
Ligand excluded by PLIPCL.100: 3 residues within 4Å:- Chain C: R.509
- Chain H: R.515
- Ligands: SO4.99
Ligand excluded by PLIP- 8 x TN6: diethylphosphoramidic acid(Covalent)
TN6.6: 10 residues within 4Å:- Chain A: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.231, A:V.288, A:F.329
- Hydrogen bonds: A:G.116, A:G.117, A:A.199
TN6.19: 10 residues within 4Å:- Chain B: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:W.231, B:V.288, B:F.329
- Hydrogen bonds: B:G.116, B:G.117, B:A.199
TN6.32: 10 residues within 4Å:- Chain C: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:W.231, C:V.288, C:F.329
- Hydrogen bonds: C:G.116, C:G.117, C:A.199
TN6.45: 10 residues within 4Å:- Chain D: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:W.231, D:V.288, D:F.329
- Hydrogen bonds: D:G.116, D:G.117, D:A.199
TN6.58: 10 residues within 4Å:- Chain E: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:W.231, E:V.288, E:F.329
- Hydrogen bonds: E:G.116, E:G.117, E:A.199
TN6.71: 10 residues within 4Å:- Chain F: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain F- Hydrophobic interactions: F:W.231, F:V.288, F:F.329
- Hydrogen bonds: F:G.116, F:G.117, F:A.199
TN6.84: 10 residues within 4Å:- Chain G: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain G- Hydrophobic interactions: G:W.231, G:V.288, G:F.329
- Hydrogen bonds: G:G.116, G:G.117, G:A.199
TN6.97: 10 residues within 4Å:- Chain H: G.115, G.116, G.117, S.198, A.199, W.231, V.288, F.329, F.398, H.438
6 PLIP interactions:6 interactions with chain H- Hydrophobic interactions: H:W.231, H:V.288, H:F.329
- Hydrogen bonds: H:G.116, H:G.117, H:A.199
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.8: 5 residues within 4Å:- Chain A: K.323, Y.420, R.515
- Chain G: R.509
- Ligands: CL.9
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain A: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain B: K.323, Y.420, R.515
- Chain F: R.509
- Ligands: CL.22
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain B: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain C: K.323, Y.420, R.515
- Chain H: R.509
- Ligands: CL.35
Ligand excluded by PLIPSO4.36: 4 residues within 4Å:- Chain C: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.47: 5 residues within 4Å:- Chain D: K.323, Y.420, R.515
- Chain E: R.509
- Ligands: CL.48
Ligand excluded by PLIPSO4.49: 4 residues within 4Å:- Chain D: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.60: 5 residues within 4Å:- Chain D: R.509
- Chain E: K.323, Y.420, R.515
- Ligands: CL.61
Ligand excluded by PLIPSO4.62: 4 residues within 4Å:- Chain E: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.73: 5 residues within 4Å:- Chain B: R.509
- Chain F: K.323, Y.420, R.515
- Ligands: CL.74
Ligand excluded by PLIPSO4.75: 4 residues within 4Å:- Chain F: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.86: 5 residues within 4Å:- Chain A: R.509
- Chain G: K.323, Y.420, R.515
- Ligands: CL.87
Ligand excluded by PLIPSO4.88: 4 residues within 4Å:- Chain G: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.99: 5 residues within 4Å:- Chain C: R.509
- Chain H: K.323, Y.420, R.515
- Ligands: CL.100
Ligand excluded by PLIPSO4.101: 4 residues within 4Å:- Chain H: Q.316, G.413, N.414, N.415
Ligand excluded by PLIP- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.11: 2 residues within 4Å:- Chain A: R.14, N.57
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain A: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: N.256, T.258, E.259
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: R.14, N.57
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: N.256, T.258, E.259
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: R.14, N.57
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain C: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: N.256, T.258, E.259
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain D: R.14, N.57
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain D: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain D: N.256, T.258, E.259
Ligand excluded by PLIPNAG.63: 2 residues within 4Å:- Chain E: R.14, N.57
Ligand excluded by PLIPNAG.64: 4 residues within 4Å:- Chain E: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain E: N.256, T.258, E.259
Ligand excluded by PLIPNAG.76: 2 residues within 4Å:- Chain F: R.14, N.57
Ligand excluded by PLIPNAG.77: 4 residues within 4Å:- Chain F: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.78: 3 residues within 4Å:- Chain F: N.256, T.258, E.259
Ligand excluded by PLIPNAG.89: 2 residues within 4Å:- Chain G: R.14, N.57
Ligand excluded by PLIPNAG.90: 4 residues within 4Å:- Chain G: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.91: 3 residues within 4Å:- Chain G: N.256, T.258, E.259
Ligand excluded by PLIPNAG.102: 2 residues within 4Å:- Chain H: R.14, N.57
Ligand excluded by PLIPNAG.103: 4 residues within 4Å:- Chain H: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.104: 3 residues within 4Å:- Chain H: N.256, T.258, E.259
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Biochem. J. (2009)
- Release Date
- 2009-05-19
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- 8 x TN6: diethylphosphoramidic acid(Covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Biochem. J. (2009)
- Release Date
- 2009-05-19
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A